Literature DB >> 11282232

Comparison of two methods of encapsulation of an oligonucleotide into poly(D,L-lactic acid) particles.

F Delie1, M Berton, E Allémann, R Gurny.   

Abstract

The aim of this study was to compare two methods to encapsulate a 25-mer-phosphorothioate oligonucleotide (ODN) into poly(D,L-lactic acid) (PLA) particles. Antisense oligonucleotides belong to a new therapeutic class especially attractive for the treatment of cancers and viral diseases. The development of these new drugs suffers, however, from poor stability in biological media and very low cellular uptake. Polymeric particulate systems display interesting features for ODN delivery. ODN are highly hydrophilic and most encapsulation methods are inappropriate for such molecules. Using poly(D,L-lactide) polymer, two methods of encapsulation were compared. First, a double emulsion technique was used to prepare nano- and microparticles. Secondly, the ODN was combined with a quaternary ammonium, the cethyltrimethyl-ammonium bromide (CTAB), to enhance the hydrophobicity of the molecule before entrapment by the emulsification-diffusion method. Both methods led to the formation of individualized and spherical particles loaded with a significant amount of ODN. Similar entrapment efficiencies were obtained for the nanoparticles prepared by both methods (approx. 27% of the theoretical loading) whereas 45% of entrapment efficiency was observed for the microparticles. Seventy five percent of the ODN were released in 60 min with the particles prepared by the emulsification-diffusion method, whereas only 7% were released in 60 h when using the double emulsion method. A viability test on U-937 cells showed better survival rates with the particles prepared by the double emulsion technique. The results suggest that the location of the ODN in the polymeric matrix is affected by the encapsulation method. Particles containing CTAB appeared more toxic than the ones obtained by the double emulsion technique, however, these particles can still be used for antisense activity since high oligonucleotide loading can be achieved.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11282232     DOI: 10.1016/s0378-5173(00)00627-x

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  10 in total

1.  Release profile and characteristics of electrosprayed particles for oral delivery of a practically insoluble drug.

Authors:  Adam Bohr; Jakob Kristensen; Mark Dyas; Mohan Edirisinghe; Eleanor Stride
Journal:  J R Soc Interface       Date:  2012-04-25       Impact factor: 4.118

Review 2.  Drug transport to brain with targeted nanoparticles.

Authors:  Jean-Christophe Olivier
Journal:  NeuroRx       Date:  2005-01

Review 3.  Methods for the preparation and manufacture of polymeric nanoparticles.

Authors:  Christine Vauthier; Kawthar Bouchemal
Journal:  Pharm Res       Date:  2008-12-24       Impact factor: 4.200

Review 4.  Nanotechnologies and controlled release systems for the delivery of antisense oligonucleotides and small interfering RNA.

Authors:  Elias Fattal; Gillian Barratt
Journal:  Br J Pharmacol       Date:  2009-04-02       Impact factor: 8.739

5.  Development of pH-sensitive insulin nanoparticles using Eudragit L100-55 and chitosan with different molecular weights.

Authors:  Mitra Jelvehgari; Parvin Zakeri-Milani; Mohammad Reza Siahi-Shadbad; Badir Delf Loveymi; Ali Nokhodchi; Zahra Azari; Hadi Valizadeh
Journal:  AAPS PharmSciTech       Date:  2010-08-05       Impact factor: 3.246

6.  The stimulation of CD8+ T cells by dendritic cells pulsed with polyketal microparticles containing ion-paired protein antigen and poly(inosinic acid)-poly(cytidylic acid).

Authors:  Michael J Heffernan; Sudhir P Kasturi; Stephen C Yang; Bali Pulendran; Niren Murthy
Journal:  Biomaterials       Date:  2008-11-25       Impact factor: 12.479

7.  Incorporation of doxorubicin in different polymer nanoparticles and their anticancer activity.

Authors:  Sebastian Pieper; Hannah Onafuye; Dennis Mulac; Jindrich Cinatl; Mark N Wass; Martin Michaelis; Klaus Langer
Journal:  Beilstein J Nanotechnol       Date:  2019-10-29       Impact factor: 3.649

Review 8.  Nanoparticulate systems for polynucleotide delivery.

Authors:  Ashwin Basarkar; Jagdish Singh
Journal:  Int J Nanomedicine       Date:  2007

Review 9.  Particles from preformed polymers as carriers for drug delivery.

Authors:  K Miladi; D Ibraheem; M Iqbal; S Sfar; H Fessi; A Elaissari
Journal:  EXCLI J       Date:  2014-02-03       Impact factor: 4.068

Review 10.  Polymeric particulates to improve oral bioavailability of peptide drugs.

Authors:  Florence Delie; María José Blanco-Príeto
Journal:  Molecules       Date:  2005-01-31       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.